Latest News

  • GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, today announced the launch of its new corporate website, cyclotherapeutics.com. “As we drive development of our potentially life-changing...
  • PHILADELPHIA – Amicus Therapeutics (Nasdaq: FOLD), today announced the election and appointment of Eiry W. Roberts, M.D. to its Board of Directors. Dr. Roberts is an esteemed drug developer who brings approximately 30 years of pharmaceutical industry experience to the Company’s Board of Directors, having served in various leadership positions...
  • SEATTLE – Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Tom Frohlich, chief business officer, has been promoted to chief operating officer (COO) of Chinook and Andrew King, D.V.M, Ph.D., head of renal discovery and translational...

Videos

Rare disease spotlight

Twitter

@JuliaHB1 The secret to stop this madness is STOP getting tested, you only fuelling numbers and causing restrictions. Feel ok? Live your life. Not feeling ok? Stay home till you get better. Don’t need a test to tell you that you’re sick!

What do you want the world to know about sickle cell? Tweet your response below 👇🏿

Starting today we are collecting your responses on topics related to #sicklecell to showcase this Saturday, June 19th–#WorldSickleCellDay. OPEN TO ALL!

#sicklecell101 #WSCD21 #sicklecellawareness

Load More...